Following today's early-morning trading update and placing announcement, Allergy has announced it has successfully raised c.£11.5m (before expenses) by way of placing 41,005,500 new ordinary shares (representing c.7.5% of the existing share capital) at 28p. With a strengthened balance sheet and ahead-of-market growth we consider both existing and planned organic opportunities, combined with a strategy to drive inorganic growth, underpin an exciting growth story for the long-term. We rai ....